General Session 2: Medical Prophylaxis and Therapy

VENOUS2025 Main Agenda

Invited Talk: DOAC: Will There Be New Targets after FXa?

Speaker(s)

• 

  John H. Fish, III, MD, FACP, FSVM, DABVLM, RPVI

  Director of Vascular Medicine
  Jobst Vascular Institute
  Toledo, Ohio, United States